Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes.
Leuk Lymphoma
; 63(2): 463-467, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-34927529
Full text:
1
Database:
MEDLINE
Main subject:
Myelodysplastic Syndromes
/
Leukemia, Myeloid, Acute
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Year:
2022
Type:
Article